Crossmark

Targeting Cancer with Sweet Precision: Saccharide-Grafted Erlotinib for Enhanced Drug Delivery

Published Online: 2024-09-28

Published Print: 2024-10

Authors

Shete, Isha

Kumbhar, Smita https://orcid.org/0000-0002-3030-9477
Dhavale, Rakesh

Bhatia, Manish
License Information

Text and Data Mining valid from 2024-09-28

Version of Record valid from 2024-09-28
More Information

Article History

Accepted: 24 September 2024

First Online: 28 September 2024

Declarations

:

: The authors declare no relevant competing interests pertaining to this article.

: The Ethics Committee has determined that no ethical approval is required for this study.

: The authors have granted their consent for publication.

Document is current